Market Tracker

01/29 6:05pm ET

Repligen Corp (NASDAQ:RGEN)

24.96
Data as of Jan 29
 +0.40 / +1.63%
Today’s Change
12.04
Today|||52-Week Range
26.75
+26.06%
Year-to-Date

Today’s Trading

Previous close24.56
Today’s open24.60
Day’s range24.20 - 25.11
Volume205,307
Average volume (3 months)340,503
Market cap$803.7M
Dividend yield--
Data as of 4:00pm ET, 01/29/2015

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-44.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio69.3
Price/Sales6.34
Price/Book7.55

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...+0.13+0.30%
FOLDAmicus Therapeutics ...+0.21+2.68%
ZIOPZIOPHARM Oncology In...+0.64+7.58%
OMEROmeros Corp+3.33+16.63%
Data as of 4:00pm ET, 01/29/2015

Financials

Next reporting dateMarch 5, 2015
EPS forecast (this quarter)$0.04
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts